SCHEMBL4097200

SCHEMBL4097200

Cc1cc(C)cc(-c2nc3ccc(C)cc3cc2C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.50
CYP1A2 P05177 3/20 0.47
PSMB5 P28074 1/20 0.46
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 5/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NCK1 P16333 1/20 0.44
BACE1 P56817 1/20 0.44
PDE3B Q13370 2/20 0.44
PDE3A Q14432 2/20 0.44
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NQO2 P16083 1/20 0.39
CYP2A6 P11509 2/20 0.39
MAPT P10636 4/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
HPGD P15428 2/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870792 0.87 PDE10A (0.49) PDE10ACYP1A2ALDH1A1KDM4EL3MBTL1
SCHEMBL4143806 0.86 PDE10A (0.56) PDE10ACYP1A2PSMB5ALDH1A1KDM4E
SCHEMBL3842193 0.85 PDE10A (0.56) PDE10ACYP1A2PSMB5ALDH1A1KDM4E
SCHEMBL28529940 0.83 PDE10A (0.73) PDE10ACYP1A2PSMB5ALDH1A1KDM4E
SCHEMBL13389141 0.83 PDE10A (0.73) PDE10ACYP1A2ALDH1A1KDM4EL3MBTL1
SCHEMBL13870788 0.82 PDE10A (0.46) PDE10ACYP1A2ALDH1A1KDM4EL3MBTL1
SCHEMBL13870810 0.81 PDE10A (0.44) PDE10APSMB5ALDH1A1KDM4EL3MBTL1
SCHEMBL13870833 0.81 KDM4E (0.47) PDE10AALDH1A1KDM4EL3MBTL1PDE3B
SCHEMBL13870814 0.81 CYP1A2 (0.41) PDE10ACYP1A2PSMB5ALDH1A1KDM4E
SCHEMBL13870797 0.81 CYP1A2 (0.41) PDE10ACYP1A2PSMB5ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101397311-B Red phosphorescent compound and use the organic electroluminescence device of described compound 乐金显示有限公司 2016-07-06 CN disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 PDE10A 1918/4885CYP1A2 3387/4885PSMB5 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.